Novavax NVAX
NASDAQ NVAX
$10.89 +0.11 (+1.02%)
At close: Nov 9, 2026 · 4:00 PM EST

Novavax (NVAX) Long-Term Investments (2012 - 2013)

Updated

Novavax (NVAX) reported Long-Term Investments of $1.12 million for Q1 2013, down 82.1% from the prior quarter.

Analysis

Novavax (NVAX) Long-Term Investments (2012 - 2013) Analysis & Trends

At the end of FY2012, Novavax posted Long-Term Investments of $6.23 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 387.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - 63.00 Mn
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 1.45 Bn
10 Novavax 1.80 Bn -1.06 Bn 44.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 1.12 Mn
Dec 31, 2012 6.23 Mn
API Access

Novavax Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=NVAX&period=max&api_key=YOUR_API_KEY